Ducommun Inc (DCO) Q3 2026 Earnings Call Transcript

Ducommun reported Q3 2026 revenue of $227.0 million, up 6% year over year, record gross margin of 28.9%, and adjusted EBITDA margin of 17.5%; bookings were $354.3 million, with a 1.6 book-to-bill ratio and record $1.3 billion RPO. Commercial aerospace revenue rose 28% to $97.4 million, offsetting a 7% decline in military and space revenue tied to order and production timing; adjusted diluted EPS was nearly flat at $1.21 versus $1.22 a year earlier. Management narrowed 2026 revenue guidance to $885 million–$890 million and set Vision 2032 targets of $1.6 billion–$1.7 billion in revenue and a 23% adjusted EBITDA margin, while citing potential destocking headwinds and a potentially material Guaymas fire-related subrogation claim.

Analysis

DCO’s key inflection is potential operating leverage from a mix of commercial aerospace recovery and defense order conversion, not the quarter’s headline growth. The market may be treating bookings and long-range targets as near-term earnings: framework awards are not purchase orders, and a high book-to-bill can coexist with uneven shipments, working-capital needs, and margin volatility. The most consequential near-term verification is whether expected missile purchase orders begin flowing in late Q1/Q2 2027 and whether the new Airbus pricing sustains Structural Systems margins; that segment’s margin deterioration shows consolidated record margins do not mean all operations are improving.

Over the next 1–3 months, Boeing/Airbus production and the end of destocking are the commercial catalysts, but supplier shipments can lag OEM build rates. For 6–18 months, defense offloads and higher engineered-product mix could lift returns without major new capacity, while execution risk shifts toward labor, training, and delivery quality. The stated Vision 2032 growth and margin goals depend partly on acquisitions; a larger deal could dilute returns or increase leverage before synergies arrive. Also monitor cash conversion: operating cash benefited partly from contract liabilities, which may reverse as deliveries progress. Guaymas claims are a discrete, potentially material downside, not a broad read-through to every facility.

Contrarian angle: strong bookings may already be doing more work in the narrative than in reported earnings, with adjusted EPS essentially flat and Structural Systems margins lower. Avoid extrapolating the quarter’s commercial growth rate. Without valuation and estimate data, this supports a catalyst-driven watch/scale-in framework rather than an unconditional chase.

Key Decisions for Investors

• DCO: Prefer staged entry on weakness rather than chasing the results. Reassess when defense framework awards convert to purchase orders and reported revenue; the thesis weakens if conversion slips beyond Q2 2027 or defense backlog fails to translate into shipments.
• Track Structural Systems adjusted operating margin and Airbus pricing realization through 2027. A continued decline despite higher commercial volumes would challenge the margin-expansion case; sustained recovery would support the higher-quality engineered-content thesis.
• Use BA production and supplier shipment cadence as a near-term read-through, not as a proxy for DCO revenue. Watch for renewed destocking, MAX build-rate delays, or delivery disruptions that would defer supplier volumes.
• Treat M&A as a two-sided catalyst: monitor deal size, funding, and expected returns before assigning value to the Vision 2032 targets. A debt-funded acquisition without clear margin or cash-flow contribution could offset organic progress.
• Monitor Guaymas litigation updates, working-capital cash conversion, and structural-segment manufacturing costs as downside alerts; no separate options trade is warranted without valuation, implied-volatility, and position-level data.